All News

Pharmacists enhancing chronic disease management through personalized care, education, and community collaboration.

Pharmacists play a crucial role in winter health, offering vaccinations, managing chronic conditions, and combating misinformation to keep communities healthy.

Researchers want to bolster evidence regarding the known link between maternal mental health and childhood nutritional status.

Episode 5 explores insulin management as well as the insulin products, doses, and administration tools all pharmacists should be familiar with for their patients with diabetes.

President Trump signed into law HR 2483, also known as the SUPPORT for Patients and Communities Reauthorization Act of 2025.

Multifaceted antimicrobial stewardship initiatives significantly enhance antibiotic prescribing practices for respiratory infections, improving patient outcomes.

In part 3 of our interview with John C. Goodman, PhD, he discusses how TrumpRx could impact the drug supply chain—specifically PBMs.

Independent pharmacies face significant challenges—such as software limitations, staffing shortages, and inconsistent billing requirements—that hinder fair reimbursement for clinical services.

Researchers explore community-acquired pneumococcal-related hospital admissions among adults from 2000 to 2019 and assess pneumococcal immunization’s impact after the year 2015.

Person-centric packaging enhances medication adherence for type 2 diabetes patients, simplifying therapy and improving outcomes, according to recent studies.

John C. Goodman, PhD, discusses TrumpRx’s impact on patients and pharmacies, comparing this administration’s approach with the previous Biden Administration.

John C. Goodman, PhD, senior fellow at the Independent Institute, discusses TrumpRx and its goals for patients’ OOP drug costs.

Dietary nutrients show promise in reducing asthma risk linked to indoor air pollution, offering new strategies for pharmacists in patient care.

The agency’s findings spur promises of significant change to the development and recommendations surrounding various immunizations.

Researchers investigate serotype distribution and antimicrobial resistance among children in Mexico with pneumococcal meningitis.

Morgan McSweeney, PhD, discusses America's public health decision-making, urging reforms to combat misinformation and safeguard scientific integrity in health agencies.

Jeffrey Bratberg, PharmD, BCPS, and Michelle Caetano, PharmD, BCACP, CVDOE, CDOE, BCPT, discuss the Pharmacy Bridge resource and pharmacists’ role in OUD management.

Conflicting federal health guidance creates confusion and erodes public trust, impacting patient safety and access to vital medical interventions.

Patient safety organizations began in the early 21st century to improve health care safety measures amongst various providers’ practices.

Researchers conduct a cost-effectiveness analysis to uncover the public health and economic impacts of PCV20 among Australian children.

Community pharmacies are facing major barriers due to PBM practices and vertical integration, ultimately jeopardizing patient access and trust in health care.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Wesley Sparkmon, PhD, MPH, assistant professor of pharmacy sciences at Creighton University.

Novo Nordisk announced results of the evoke and evoke+ phase 3 trials on semaglutide’s use in treating Alzheimer disease progression.

Catie Stimmel, PharmD, discusses the pharmacist’s role in ensuring PSOs operate at their intended capabilities.

Key sessions from the National Community Pharmacists Association 2025 Annual Convention & Expo highlight pharmacy benefit manager reform, pneumococcal vaccines, and billable services.

Morgan McSweeney, PhD, discusses how social media highlights the most emotionally charged voices, often those offering anecdotes or outrage over careful analysis.

Tardive dyskinesia presents significant challenges for patients, but new FDA-approved treatments offer hope for improved management and quality of life.

Catie Stimmel, PharmD, explores the confidentiality and non-punitive processes that are crucial in driving value toward patient safety organizations.